These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 104991)

  • 41. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and characteristics of pyocin B39 II. Physical and chemical properties.
    Chen C; Tai F
    Antimicrob Agents Chemother; 1972 Feb; 1(2):159-63. PubMed ID: 4218942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa.
    Sano Y; Matsui H; Kobayashi M; Kageyama M
    J Bacteriol; 1993 May; 175(10):2907-16. PubMed ID: 8491711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential.
    Uratani Y; Hoshino T
    J Bacteriol; 1984 Feb; 157(2):632-6. PubMed ID: 6420392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plant-expressed pyocins for control of Pseudomonas aeruginosa.
    Paškevičius Š; Starkevič U; Misiūnas A; Vitkauskienė A; Gleba Y; Ražanskienė A
    PLoS One; 2017; 12(10):e0185782. PubMed ID: 28973027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of antibiotic resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Tzouvelekis LS; Tumah H; Malliara K; Legakis NJ
    J Chemother; 1989 Aug; 1(4):226-30. PubMed ID: 2509643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction and characterization of pyocin-colicin chimeric proteins.
    Kageyama M; Kobayashi M; Sano Y; Masaki H
    J Bacteriol; 1996 Jan; 178(1):103-10. PubMed ID: 8550402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of R-pyocin activity against Gram-positive pathogens for the first time with special focus on Staphylococcus aureus.
    Mohamed AA; Elshawadfy AM; Amin G; Askora A
    J Appl Microbiol; 2021 Dec; 131(6):2780-2792. PubMed ID: 33977611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins.
    Ghequire MG; Dingemans J; Pirnay JP; De Vos D; Cornelis P; De Mot R
    Microbiologyopen; 2014 Dec; 3(6):875-84. PubMed ID: 25224846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification and characterization of pyocins from Pseudomonas aeruginosa.
    Al-Shibib A; Al-Mudhaffar S; Al-Ani F; Hassan F
    Folia Microbiol (Praha); 1985; 30(1):25-9. PubMed ID: 3920127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pyocins of Pseudomonas aeruginosa.
    Michel-Briand Y; Baysse C
    Biochimie; 2002; 84(5-6):499-510. PubMed ID: 12423794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189.
    Naz SA; Jabeen N; Sohail M; Rasool SA
    Braz J Microbiol; 2015; 46(4):1147-54. PubMed ID: 26691474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the host range specificity of pyocin P1.
    Brandis H; Krämer J; Israil A
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):13-20. PubMed ID: 813612
    [No Abstract]   [Full Text] [Related]  

  • 55. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage.
    Ling H; Saeidi N; Rasouliha BH; Chang MW
    FEBS Lett; 2010 Aug; 584(15):3354-8. PubMed ID: 20580355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of defocusing on the electron microscopic image of the extended particle of pyocin R1.
    Takeda Y; Kageyama M
    J Biochem; 1983 Sep; 94(3):1013-6. PubMed ID: 6417116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage.
    Farmer JJ; Herman LG
    Appl Microbiol; 1969 Nov; 18(5):760-5. PubMed ID: 4984201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulfhydryl groups of pyocin R1. Morphology and activity modified with sulfhydryl reagents.
    Hasegawa T; Terayama K; Azegami M; Ishii S
    J Biochem; 1979 Apr; 85(4):977-88. PubMed ID: 110797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retargeting R-type pyocins to generate novel bactericidal protein complexes.
    Williams SR; Gebhart D; Martin DW; Scholl D
    Appl Environ Microbiol; 2008 Jun; 74(12):3868-76. PubMed ID: 18441117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possibility of using purified pyocins for typing Pseudomonas aeruginosa: purification of pyocins and sensitivity of P. aeruginosa in different tests.
    Jurado Chacon D; Chueca Sancho A; Guillen Solvas JF; Garcia-Villanova Ruiz B; Galvez Vargas R
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(3):253-66. PubMed ID: 3122639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.